Curcumin Paste as an Adjunctive Therapy in Periodontitis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04032132 |
Recruitment Status :
Completed
First Posted : July 25, 2019
Last Update Posted : July 25, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Periodontitis | Drug: curcumin paste Procedure: curettage | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 24 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | The Local Application of Curcumin in Conjunction With the Surgical Treatment of Intrabony Periodontal Defects "Controlled Clinical Study With Evaluation of Curcumin Release Profile" |
Actual Study Start Date : | August 20, 2016 |
Actual Primary Completion Date : | May 6, 2018 |
Actual Study Completion Date : | November 5, 2018 |

Arm | Intervention/treatment |
---|---|
Experimental: curcumin paste in conjunction with open flap debridement surge
curcumin paste (2% circumin) in conjunction with open flap debridement surgery
|
Drug: curcumin paste
curcumin is a herb used for medical purpose Procedure: curettage open flab debridement surgery |
Placebo Comparator: open flap debridement surgery only
surgical treatment for periodontal pocket
|
Procedure: curettage
open flab debridement surgery |
- clinical score [ Time Frame: change from base line at 6 months ]Evaluate the influence of curcumin paste on the clinical outcomes of the surgical treatment.to see if curcumin has a positive effect in reduction oh deep periodontal pockets and leads to greater bone gain

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 25 Years to 45 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Male or female with age range 25-45 years.
- At least a single posterior 2-3 wall periodontal defect of pocket depth ≥ 5mm; clinical attachment level ≥ 3 mm, Intrabony component ≥ 3 mm and with plaque index ≤1 (Löe 1967) and bleeding index ≤1 (Mühlemann & Son 1971). All the previous criteria were determined 2 weeks after phase I conventional periodontal therapy.
- Systemically Healthy as evidenced by Burket's oral medicine health history questionnaire (Glick et al., 2008).
Exclusion Criteria:
- 1- Smokers. 2- Pregnant. 3- Patient unwilling to comply to periodontaloral hygienic instructions. 4- Vulnerable groups. (e.g: Decisionally impaired individual)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04032132
Study Director: | Ahmed Y Gamal, professor | Faculty of dentistry -Ain Shams university |
Responsible Party: | Yasmine Gamal, Administrator of oral medicine and periodontology, Ain Shams University |
ClinicalTrials.gov Identifier: | NCT04032132 |
Other Study ID Numbers: |
FER16 20-M |
First Posted: | July 25, 2019 Key Record Dates |
Last Update Posted: | July 25, 2019 |
Last Verified: | July 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | Yes |
curcumin CBCT HPLC periodontitis |
Periodontitis Periodontal Diseases Mouth Diseases Stomatognathic Diseases Curcumin Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics |
Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Inflammatory Agents Antirheumatic Agents Antineoplastic Agents Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |